Login / Signup

Epicrestal and subcrestal placement of platform-switched implants: 18 month-result of a randomized, controlled, split-mouth, prospective clinical trial.

Stuart J FroumSang-Choon ChoTakanori SuzukiPaul YuPatricia CorbyIsmael Khouly
Published in: Clinical oral implants research (2018)
The MBL changes around platform-switched implants with same geometry were not affected by the epicrestal or subcrestal location of the IAJ. Furthermore, the location of the IAJ did not affect the implant survival and soft tissue dimensions. However, no bone loss was located apical to the IAJ when the implants were placed subcrestally.
Keyphrases
  • soft tissue
  • bone loss
  • clinical trial
  • high throughput
  • phase ii